Advertisement

American Journal of Clinical Dermatology

, Volume 18, Issue 2, pp 165–168 | Cite as

Need For Improved Skin Cancer Surveillance in Pediatric Cancer Survivors

  • Divya Sharma
  • Thomas Lee
  • Adam J. Friedman
  • Kelley Pagliai Redbord
Current Opinion

Abstract

Survivors of pediatric cancer are at increased risk of developing secondary malignancies, with non-melanoma skin cancer being the most common. These patients are also at increased risk of melanoma. Currently, guidelines provided by the National Cancer Institute and Children’s Oncology Group emphasize the importance of annual clinical examination for skin cancer screening; however, the literature reports that less than one-third of survivors of pediatric cancer have ever had a clinical skin exam by a physician. In this article, we review the risk factors for skin cancer in survivors of pediatric cancer as well as the current evidence and recommendations for their care. We suggest that dermatologists collectively establish guidelines for skin cancer surveillance in survivors of pediatric cancer.

Notes

Compliance with Ethical Standards

Funding

No sources of funding were used to conduct this study or prepare this manuscript.

Conflict of interest

The authors have no conflicts of interest that are directly relevant to the content of this article.

References

  1. 1.
    Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23(16):3733–41.CrossRefPubMedGoogle Scholar
  2. 2.
    Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083–95.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973–2002. Int J Cancer. 2007;121(10):2233–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006;24(7):1119–26.CrossRefPubMedGoogle Scholar
  5. 5.
    Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011;117(1):316–22.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Janin A, Murata H, Leboeuf C, Cayuela JM, Gluckman E, Legres L, et al. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation. Blood. 2009;113(8):1834–40.CrossRefPubMedGoogle Scholar
  7. 7.
    Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105(10):3802–11.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014;25(2):435–41.CrossRefPubMedGoogle Scholar
  9. 9.
    Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2 Pt 1):177–86.CrossRefPubMedGoogle Scholar
  10. 10.
    Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49(3):506–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Kovach BT, Stasko T. Skin cancer after transplantation. Transpl Rev (Orlando). 2009;23(3):178–89.CrossRefGoogle Scholar
  12. 12.
    Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2012;104(16):1240–50.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2013;60(3):461–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Ehrhardt MJ, Bhakta N, Liu Q, Yasui Y, Krasin MJ, Mulrooney DA, et al. Absence of basal cell carcinoma in irradiated childhood cancer survivors of black race: a report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol Biomark Prev. 2016;25(9):1356–60.CrossRefGoogle Scholar
  15. 15.
    Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res. 2002;157(4):410–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336(13):897–904.CrossRefPubMedGoogle Scholar
  17. 17.
    Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154(3):472–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Lawless SC, Verma P, Green DM, Mahoney MC. Mortality experiences among 15 + year survivors of childhood and adolescent cancers. Pediatr Blood Cancer. 2007;48(3):333–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2328–38.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Baldwin S, Au S. One-year review of the SCREEN (Skin Cancer Post-Transplant) Clinic: what we have learned. J Cutan Med Surg. 2016. https://www.ncbi.nlm.nih.gov/pubmed/27663613.
  21. 21.
    Hansson J, Bergenmar M, Hofer PA, Lundell G, Mansson-Brahme E, Ringborg U, et al. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. J Clin Oncol. 2007;25(19):2819–24.CrossRefPubMedGoogle Scholar
  22. 22.
    Transplantation EEGoR. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transpl. 2002;17(Suppl 4):31–6.Google Scholar
  23. 23.
    Late Effects of Treatment for Childhood Cancer (PDQ®). http://www.cancer.gov/cancertopics/pdq/treatment/lateeffects/Patient/page2. Accessed 15 Aug 2016.
  24. 24.
    Daniel CL, Armstrong GT, Keske RR, Davine JA, McDonald AJ, Sprunck-Harrild KM, et al. Advancing Survivors’ Knowledge (ASK) about skin cancer study: study protocol for a randomized controlled trial. Trials. 2015;16:109.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 3.0. http://www.survivorshipguidelines.org/. Accessed 15 Aug 2016.
  26. 26.
  27. 27.
    Basal Cell Carcinoma: Who Gets and Causes. https://www.aad.org/public/diseases/skin-cancer/basal-cell-carcinoma#causes. Accessed 15 Aug 2016.
  28. 28.
    Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2016;316(4):436–47.CrossRefPubMedGoogle Scholar
  29. 29.
    Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Ebell M, et al. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429–35.Google Scholar
  30. 30.
    Stapleton JL, Tatum KL, Devine KA, Stephens S, Masterson M, Baig A, et al. Skin cancer surveillance behaviors among childhood cancer survivors. Pediatr Blood Cancer. 2016;63(3):554–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Greenberg JN, Zwald FO. Management of skin cancer in solid-organ transplant recipients: a multidisciplinary approach. Dermatol Clin. 2011;29(2):231–41, ix.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Divya Sharma
    • 1
  • Thomas Lee
    • 2
  • Adam J. Friedman
    • 2
  • Kelley Pagliai Redbord
    • 2
  1. 1.Department of MedicineThe Warren Alpert Medical School of Brown University and Rhode Island HospitalProvidenceUSA
  2. 2.Department of DermatologyGeorge Washington School of Medicine and Health Sciences, Medical Faculty Associates at the George Washington UniversityWashingtonUSA

Personalised recommendations